Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients

Oral Oncology

Volumn 45, Issue 12, 2009, Pages 1051-1057

  Šupić, Gordana ^a   Kozomara, Ružica ^a   Branković Magić, Mirjana ^b   Jović, Nebojša ^a   Magić, Zvonko ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

DNA methylation; E cadherin; Oral squamous cell carcinoma; Overall survival

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; DNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; UVOMORULIN; WERNER SYNDROME PROTEIN; WNT PROTEIN;

ADULT; APOPTOSIS; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL ADHESION; CELL CYCLE REGULATION; CONTROLLED STUDY; DNA REPAIR; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; MOUTH CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL CYCLE; DNA METHYLATION; DNA REPAIR; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMERASE CHAIN REACTION; SERBIA; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; WNT PROTEINS;

EID: 70449592332     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.07.007     Document Type: Article

References (53)

1. Tsantoulis P.K., Kastrinakis N.G., Tourvas A.D., Laskaris G., and Gorgoulis V.G. Advances in the biology of oral cancer. Oral Oncol 43 (2007) 523-534
2. Forastiere A., Koch W., Trotti A., and Sidransky D. Head and neck cancer. N Engl J Med 345 (2001) 1890-1900
3. Scully C., and Bagan J.V. Recent advances in oral oncology. Oral Oncol 43 (2007) 107-115
4. Williams H.K. Molecular pathogenesis of oral squamous carcinoma. J Clin Pathol Mol Pathol 53 (2000) 165-172
5. Kozomara R., Jović N., Magić Z., Branković-Magić M., and Minić V. P53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival. J Craniomaxillofac Surg 33 (2005) 342-348
6. Herman J.G., and Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N Eng J Med 349 (2003) 2042-2054
7. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nature 3 (2002) 415-428
8. Esteller M., Corn P.G., Baylin S.B., and Herman J.G. A gene hypermethylation profile of human cancer. Cancer Res 61 (2001) 3225-3229
9. Gil J., and Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev (Mol Cell Biol) 7 (2006) 667-677
10. Auerkari E.I. Methylation of tumor suppressor genes p16(INK4a), p27(Kip1) and E-cadherin in carcinogenesis. Oral Oncol 42 (2006) 5-13
11. Shaw R. The epigenetics of oral cancer. Int J Oral Maxillofac Surg 35 (2006) 101-108
12. Raveh T., Droguett G., Horwitz M.S., DePinho R.A., and Kimchi A. Nat Cell Biol 3 (2001) 1-7
13. Sanchez-Cespedes M., et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60 (2000) 892-895
14. Rosas S.L., et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and DAP-kinase in tumors and saliva of head and neck cancer patients. Cancer Res 61 (2001) 939-942
15. Kudo Y., et al. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clin Cancer Res 10 (2004) 5455-5463
16. Hasegawa M., et al. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 21 (2002) 4231-4236
17. de Moraes R.V., et al. E-cadherin abnormalities resulting from CpG methylation promoter in metastatic and nonmetastatic oral cancer. Head Neck 30 (2008) 85-92
18. Chang H.W., Chow V., Lam K.Y., Wei W.I., and Yuen A. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer 94 (2002) 386-392
19. Fearnhead N.S., Britton M.P., and Bodmer W.F. The ABC of APC. Hum Mol Genet 10 (2001) 721-733
20. Esteller M., et al. Analysis of adenomatous Polyposis Coli promoter hypermethylation in human. Cancer Res 60 (2000) 4366-4371
21. Chen K., et al. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 133 (2007) 1131-1138
22. Uesugi H., et al. Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma. Int J Mol Med 15 (2005) 597-602
23. Jacinto F.V., and Esteller M. Mutator pathways unleashed by epigenetic silencing in human cancer. Mutagenesis 22 (2007) 247-253
24. Kulkarni V., and Saranath D. Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues. Oral Oncol 40 (2004) 145-153
25. Esteller M., et al. Hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase and survival of patients with diffuse large B-Cell lymphoma. J Natl Cancer Inst 94 (2002) 26-32
26. Sawhney M., et al. MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis. Oral Oncol 43 (2007) 515-522
27. Agrelo R., et al. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc Natl Acad Sci USA 103 (2006) 8822-8827
28. Palmisano W.A., et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60 (2000) 5954-5958
29. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93 (1996) 9821-9826
30. Belinsky S.A., et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 62 (2002) 2370-2377
31. Corn P.G., et al. E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia. Clin Cancer Res 6 (2000) 4243-4248
32. van Engeland M., et al. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands cohort study on diet and cancer. Cancer Res 63 (2003) 3133-3137
33. Ogi K., et al. Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res 8 (2002) 3164-3171
34. Sailasree R., et al. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma. Cancer Epidemiol Biomarkers Prev 17 (2008) 414-420
35. Koscielny S., Dahse R., Ernst G., and von Eggeling F. The prognostic relevance of p16 inactivation in head and neck cancer. ORL J Otorhinolaryngol Relat Spec 69 (2007) 30-36
36. Graziano F., et al. Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer. Clin Cancer Res 10 (2004) 2784-2789
37. Nakata S., et al. The methylation status and protein expression of CDH1, p16 (INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. Cancer 106 (2006) 2190-2199
38. Marsit C.J., Posner M.R., McClean M.D., and Kelsey K.T. Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma. Cancer 113 (2008) 1566-1571
39. De Schutter H., Geeraerts H., Verbeken E., and Nuyts S. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only. Oncol Rep 21 (2009) 507-513
40. Saito Y., Takazawa H., Uzawa K., Tanzawa H., and Sato K. Reduced expression of Ecadherin in oral squamous cell carcinoma: relationship with DNA methylation of 5'CpG island. Int J Oncol 12 (1998) 293-298
41. Foschini M.P., et al. E-cadherin loss and DNP73l expression in oral squamous cell carcinomas showing aggressive behavior. Head Neck 30 (2008) 1475-1482
42. Kurtz K.A., Hoffman H.T., Zimmerman M.B., and Robinson R.A. Decreased E-cadherin but not beta-catenin expression is associated with vascular invasion and decreased survival in head and neck squamous carcinomas. Otolaryngol Head Neck Surg 134 (2006) 142-146
43. Zhang W., et al. E-cadherin loss promotes the initiation of squamous cell carcinoma invasion through modulation of integrin-mediated adhesion. J Cell Sci 119 (2006) 283-291
44. Mandal M., et al. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 112 (2008) 2088-2100
45. Kim Y.T., et al. Aberrant promoter CpG island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor by affecting lymph node metastasis in squamous cell carcinoma of the esophagus. Dis Esophagus 22 (2009) 143-150
46. Zare M., et al. Qualitative analysis of adenomatous polyposis coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker. BMC Cancer 9 (2009) 24 10.1186/1471-2407-9-2
47. Inbal B., et al. DAP kinase links the control of apoptosis to metastasis. Nature 390 (1997) 180-184
48. 6-Methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 13 (2004) 967-975
49. Esteller M., et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343 (2000) 1350-1354
50. Sawhney M., et al. MGMT expression in oral precancerous and cancerous lesions: Correlation with progression, nodal metastasis and poor prognosis. Oral Oncol 43 (2007) 515-522
51. Maruya S., et al. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res 10 (2004) 3825-3830
52. Lopez M., et al. Gene promoter hypermethylation in oral rinses of leukoplakia patients-a diagnostic and/or prognostic tool?. Eur J Cancer 39 (2003) 2306-2309
53. Brock M.V., et al. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res 9 (2003) 2912-2919